Coronary arterial thrombi in Kawasaki disease. 1985

M Terai, and M Ogata, and K Sugimoto, and Y Nagai, and T Toba, and K Tamai, and H Aotsuka, and K Niwa, and H Nakajima

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D009080 Mucocutaneous Lymph Node Syndrome An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities. Kawasaki Disease,Lymph Node Syndrome, Mucocutaneous,Kawasaki Syndrome
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000783 Aneurysm Pathological outpouching or sac-like dilatation in the wall of any blood vessel (ARTERIES or VEINS) or the heart (HEART ANEURYSM). It indicates a thin and weakened area in the wall which may later rupture. Aneurysms are classified by location, etiology, or other characteristics. Saccular Aneurysm,Fusiform Aneurysm,Aneurysm, Fusiform,Aneurysms,Aneurysms, Fusiform,Fusiform Aneurysms
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator

Related Publications

M Terai, and M Ogata, and K Sugimoto, and Y Nagai, and T Toba, and K Tamai, and H Aotsuka, and K Niwa, and H Nakajima
August 1991, Acta paediatrica Japonica : Overseas edition,
M Terai, and M Ogata, and K Sugimoto, and Y Nagai, and T Toba, and K Tamai, and H Aotsuka, and K Niwa, and H Nakajima
August 2009, Cardiology in the young,
M Terai, and M Ogata, and K Sugimoto, and Y Nagai, and T Toba, and K Tamai, and H Aotsuka, and K Niwa, and H Nakajima
February 1979, Kokyu to junkan. Respiration & circulation,
M Terai, and M Ogata, and K Sugimoto, and Y Nagai, and T Toba, and K Tamai, and H Aotsuka, and K Niwa, and H Nakajima
October 1994, The American journal of cardiology,
M Terai, and M Ogata, and K Sugimoto, and Y Nagai, and T Toba, and K Tamai, and H Aotsuka, and K Niwa, and H Nakajima
January 1993, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui,
M Terai, and M Ogata, and K Sugimoto, and Y Nagai, and T Toba, and K Tamai, and H Aotsuka, and K Niwa, and H Nakajima
January 1987, Progress in clinical and biological research,
M Terai, and M Ogata, and K Sugimoto, and Y Nagai, and T Toba, and K Tamai, and H Aotsuka, and K Niwa, and H Nakajima
August 1999, The American journal of cardiology,
M Terai, and M Ogata, and K Sugimoto, and Y Nagai, and T Toba, and K Tamai, and H Aotsuka, and K Niwa, and H Nakajima
November 1998, The American journal of cardiology,
M Terai, and M Ogata, and K Sugimoto, and Y Nagai, and T Toba, and K Tamai, and H Aotsuka, and K Niwa, and H Nakajima
November 1985, The American journal of cardiology,
M Terai, and M Ogata, and K Sugimoto, and Y Nagai, and T Toba, and K Tamai, and H Aotsuka, and K Niwa, and H Nakajima
May 1996, Circulation,
Copied contents to your clipboard!